Studies have found that Von Hippel–Lindau-deficient cells expressing FTO reduced the m6A level of PGC-1α mRNA, stabilizing PGC-1α mRNA, restoring mitochondrial activity, promoting oxidative stress and ROS production, and thus inhibiting tumor growth [218]. This evidence concerns the gene FTO and neoplasm.